China Oncology ›› 2014, Vol. 24 ›› Issue (7): 512-516.doi: 10.3969/j.issn.1007-3969.2014.07.006

Previous Articles     Next Articles

A study on the relationship of the activity of aryl hydrocarbon receptor and aryl hydrocarbon metabolic enzymes in peripheral blood and breast cancer

WANG Tian-hang1,LU Ying1,YANG Xiao-yan1,OU Jiang-hua2   

  1. 1.The Public Health College of Xinjiang Medical University, Urumqi Xinjiang 833000,China;
    2. Department of Breast Surgery, Affiliated Cancer Hospital of XinJiang Medical University, Urumqi Xinjiang 833000, China
  • Online:2014-07-30 Published:2014-07-29
  • Contact: YANG Xiao-yan E-mail: 390068143@qq.com

Abstract:

Background and purpose: Previous studies showed activated aryl hydrocarbon receptor (AhR) might be involved in the development of breast cancer induced by polycyclic aromatic hydrocarbons (PHAs) and AhR which was regarded as transcription factors activated by ligand could induced many enzymes expression. Therefore, this study aimed to explore the protein level of AhR and aryl hydrocarbon metabolic enzymes in vivo with a relationship of the breast cancer and pathology indicators. Methods: A case-control study was 11 matched and 65 pairs blood samples were collected, the ELISA was used in testing blood protein levels of the aromatic hydrocarbon receptor and aryl hydrocarbon metabolic enzymes. Meanwhile pathological data was collected. The Rank sum test statistical analysis was used in analyzing measurement data, Spearman test was used in correlation analysis. Results: Statistical analysis revealed that there was no statistical difference in aldehyde dehydrogenase(ALDH), cytochrome P450(CYP450) between the case group and the control group (Z=0.196,P=0.845;Z=0.269,P=0.788);and the AhR, NQO1, GST control group concentrations were lower than that in the case group. There were statistical differences of AhR, quinone oxido-ereductase 1(NQO1), glutatnione-S-transferases(GST) between the control group and the case group(Z=1.956, P=0.041; Z=2.627, P=0.009; Z=3.272, P=0.001). Correlation analysis showed that AhR has a higher correlation in case group with GST, NQO1 (r=0.665, P<0.01; r=0.704, P<0.01). Grouping with the pathology indicators (ER, PR, HER-2) -,+,++,+++, found that the level of grouping by ER, AhR protein levels and GST protein levels have a discrepancies(P<0.05). Conclusion: These results might suggest that the protein levels of AhR and aryl hydrocarbon metabolic enzymes have a significant impact on breast cancer. Detection of enzyme protein levels may be helpful for early detection of breast cancer, prompt treatment options and prognosis are meaningful.

Key words: Breast cancer, Aryl hydrocarbon receptor, Plasma protein concentration